Fisher Asset Management
GSK icon

Fisher Asset Management’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.2B Buy
31,338,405
+1,306,590
+4% +$50.2M 0.48% 63
2025
Q1
$1.16B Buy
30,031,815
+11,195,018
+59% +$434M 0.5% 65
2024
Q4
$637M Buy
18,836,797
+259,867
+1% +$8.79M 0.25% 83
2024
Q3
$759M Buy
18,576,930
+870,449
+5% +$35.6M 0.31% 79
2024
Q2
$682M Buy
17,706,481
+2,038,221
+13% +$78.5M 0.3% 84
2024
Q1
$672M Buy
15,668,260
+631,379
+4% +$27.1M 0.31% 85
2023
Q4
$557M Buy
15,036,881
+1,436,488
+11% +$53.2M 0.29% 88
2023
Q3
$493M Sell
13,600,393
-221,437
-2% -$8.03M 0.28% 98
2023
Q2
$493M Buy
13,821,830
+547,165
+4% +$19.5M 0.27% 101
2023
Q1
$473M Buy
13,274,665
+554,079
+4% +$19.7M 0.29% 104
2022
Q4
$447M Buy
12,720,586
+548,735
+5% +$19.3M 0.3% 89
2022
Q3
$358M Sell
12,171,851
-7,396,273
-38% -$218M 0.27% 94
2022
Q2
$852M Buy
19,568,124
+600,915
+3% +$26.2M 0.6% 53
2022
Q1
$826M Buy
18,967,209
+750,042
+4% +$32.7M 0.49% 64
2021
Q4
$803M Buy
18,217,167
+386,767
+2% +$17.1M 0.45% 60
2021
Q3
$681M Buy
17,830,400
+282,409
+2% +$10.8M 0.42% 65
2021
Q2
$699M Buy
17,547,991
+526,006
+3% +$20.9M 0.44% 62
2021
Q1
$608M Buy
17,021,985
+495,391
+3% +$17.7M 0.43% 65
2020
Q4
$608M Buy
16,526,594
+300,377
+2% +$11.1M 0.46% 62
2020
Q3
$611M Buy
16,226,217
+348,044
+2% +$13.1M 0.53% 51
2020
Q2
$648M Buy
15,878,173
+338,208
+2% +$13.8M 0.63% 43
2020
Q1
$589M Buy
15,539,965
+127,004
+0.8% +$4.81M 0.73% 43
2019
Q4
$724M Buy
15,412,961
+145,373
+1% +$6.83M 0.73% 43
2019
Q3
$652M Buy
15,267,588
+1,412,368
+10% +$60.3M 0.72% 43
2019
Q2
$554M Sell
13,855,220
-720,783
-5% -$28.8M 0.61% 50
2019
Q1
$609M Buy
14,576,003
+473,443
+3% +$19.8M 0.71% 43
2018
Q4
$539M Buy
14,102,560
+91,232
+0.7% +$3.49M 0.74% 42
2018
Q3
$563M Buy
14,011,328
+187,205
+1% +$7.52M 0.68% 44
2018
Q2
$557M Buy
13,824,123
+395,779
+3% +$16M 0.72% 39
2018
Q1
$525M Buy
13,428,344
+648,623
+5% +$25.3M 0.7% 43
2017
Q4
$453M Sell
12,779,721
-48,530
-0.4% -$1.72M 0.59% 53
2017
Q3
$521M Buy
12,828,251
+293,866
+2% +$11.9M 0.73% 45
2017
Q2
$540M Buy
12,534,385
+564,519
+5% +$24.3M 0.82% 38
2017
Q1
$505M Buy
11,969,866
+160,366
+1% +$6.76M 0.81% 40
2016
Q4
$455M Sell
11,809,500
-51,672
-0.4% -$1.99M 0.79% 41
2016
Q3
$512M Buy
11,861,172
+130,297
+1% +$5.62M 0.91% 32
2016
Q2
$511M Buy
11,730,875
+73,020
+0.6% +$3.18M 0.95% 35
2016
Q1
$500M Buy
11,657,855
+126,182
+1% +$5.41M 0.95% 35
2015
Q4
$465M Buy
11,531,673
+3,604
+0% +$145K 0.9% 41
2015
Q3
$443M Sell
11,528,069
-5,302
-0% -$204K 0.92% 39
2015
Q2
$480M Buy
11,533,371
+776,291
+7% +$32.3M 0.93% 39
2015
Q1
$496M Sell
10,757,080
-7,924
-0.1% -$366K 0.99% 35
2014
Q4
$460M Sell
10,765,004
-723,590
-6% -$30.9M 0.95% 37
2014
Q3
$528M Buy
11,488,594
+122,691
+1% +$5.64M 1.13% 35
2014
Q2
$608M Buy
11,365,903
+151,539
+1% +$8.1M 1.28% 29
2014
Q1
$599M Buy
11,214,364
+103,455
+0.9% +$5.53M 1.35% 27
2013
Q4
$593M Sell
11,110,909
-8,172
-0.1% -$436K 1.34% 27
2013
Q3
$558M Sell
11,119,081
-29,194
-0.3% -$1.46M 1.37% 29
2013
Q2
$557M Buy
+11,148,275
New +$557M 1.45% 25